Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02022293 : Atorvastatin in Preventing Nasopharyngeal Carcinoma Patients Receiving Radiotherapy From Carotid Stenosis
PhasePhase 2
AgesMin: 40 Years Max: 65 Years
Eligibility
Inclusion Criteria:

- Patients must have received radiation therapy for histologically confirmed
nasopharyngeal carcinoma.

- Prior irradiation <3 years prior to study entry.

- Male or fertile women who are willing to take contraception during the trial.

- Age 40-65 years old.

- Carotid stenosis < 50%.

- LDL-C between 100mg/dL?2.5mmol/L?and 190mg/dL?4.9mmol/L?.

- Ability to understand and the willingness to sign a written informed consent
document.

Exclusion Criteria:

- History of bleeding related to tumor or radiotherapy during or after radiation.

- Evidence of tumor invasion to major vessels(for example the carotid artery).

- Severe complications, such as history of stroke, myocardial infarction, liver
diseases, thyroid dysfunction, inadequately controlled hypertension and epilepsy.

- Familial hypercholesterolemia.

- Taking lipid-lowing drugs.

- Aspartate aminotransferase(AST) or alanine aminotransferase(ALT) >upper limits of
normal (ULN), creatinine >ULN.

- Allergic history of atorvastatin.
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02022293      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740